These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9098843)

  • 1. The effects of triethanolamine myristate, a fatty acid salt, on the availability of riboflavin in humans.
    Forusz H; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1997; 19(1):73-6. PubMed ID: 9098843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of triethanolamine myristate, a fatty acid salt, on the bioavailability of riboflavin in dogs.
    Forusz H; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):589-91. PubMed ID: 9010833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
    Hamdani J; Goole J; Moës AJ; Amighi K
    Int J Pharm; 2006 Oct; 323(1-2):86-92. PubMed ID: 16815656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small doses of the unabsorbable substance polyethylene glycol 3350 accelerate oro-caecal transit, but slow gastric emptying in healthy subjects.
    Coremans G; Vos R; Margaritis V; Ghoos Y; Janssens J
    Dig Liver Dis; 2005 Feb; 37(2):97-101. PubMed ID: 15733521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of relative bioavailability of riboflavin by the fluid intake (author's transl)].
    Frömming KH; Mehnert W; Vetter G
    Arzneimittelforschung; 1981; 31(12):2159-62. PubMed ID: 7199319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of centrally administered C75, a fatty acid synthase inhibitor, on gastric emptying and gastrointestinal transit in mice.
    Li LF; Lu YY; Xiong W; Liu JY; Chen Q
    Eur J Pharmacol; 2008 Oct; 595(1-3):90-4. PubMed ID: 18706411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the role of cephalic stimulation of acid secretion on gastric emptying and appetite following a soup meal using the gastric acid inhibitor omeprazole.
    Cecil JE; Francis J; Read NW
    Appetite; 2004 Feb; 42(1):99-105. PubMed ID: 15036788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.
    Kagan L; Lapidot N; Afargan M; Kirmayer D; Moor E; Mardor Y; Friedman M; Hoffman A
    J Control Release; 2006 Jul; 113(3):208-15. PubMed ID: 16806558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The delay of gastric emptying induced by remifentanil is not influenced by posture.
    Walldén J; Thörn SE; Wattwil M
    Anesth Analg; 2004 Aug; 99(2):429-34, table of contents. PubMed ID: 15271718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
    Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR
    Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of stomach motility on measuring stomach permeability with saccharose in vivo].
    Griga T; Schmidthaus C; Dietrich W; May B
    Z Gastroenterol; 1999 Apr; 37(4):271-5. PubMed ID: 10378362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin pathways modulate sensations induced by gastric distension in humans.
    Lal S; McLaughlin J; Barlow J; D'Amato M; Giacovelli G; Varro A; Dockray GJ; Thompson DG
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G72-9. PubMed ID: 14764444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H; Fujibayashi Y
    J Control Release; 2004 Jul; 98(1):75-85. PubMed ID: 15245891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.